Title
Sickle Cell Disease: Cardiopulmonary and Kidney Disease
Authoring Organization
Publication Month/Year
December 3, 2019
Last Updated Month/Year
April 2, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about screening, diagnosis, and management of cardiopulmonary and renal complications of SCD.
Target Patient Population
Adults and children with sickle cell disease
Inclusion Criteria
Female, Male, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospice, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Management, Treatment
Diseases/Conditions (MeSH)
D000755 - Anemia, Sickle Cell, D000925 - Anticoagulants, D013923 - Thromboembolism
Keywords
thromboembolism, anticoagulation, sickle cell disease, Anticoagulation
Source Citation
Blood Adv (2019) 3 (23): 3867–3897.